Nucleic Acid Therapeutics : Impact Factor & More
eISSN: 2159-3345pISSN: 2159-3337
Share this on:
Key Metrics
CiteScore 
9.3
Eigenfactor
0.001 - 0.005
Impact Factor
< 5
SJR
Q1Genetics
SNIP
1.19
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Nucleic Acid Therapeutics
Nucleic Acid Therapeutics Journal Specifications
| Overview | |
| Publisher | MARY ANN LIEBERT, INC |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2011 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Nucleic Acid Therapeutics ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
FAQs on Nucleic Acid Therapeutics
How long has Nucleic Acid Therapeutics been actively publishing? 
What is the publishing frequency of Nucleic Acid Therapeutics?
What is the eISSN & pISSN for Nucleic Acid Therapeutics?
What is Citescore for Nucleic Acid Therapeutics?
What is SNIP score for Nucleic Acid Therapeutics?
What is the SJR for Nucleic Acid Therapeutics?
Who is the publisher of Nucleic Acid Therapeutics?
